The content on this site is intended for healthcare professionals only
Dr Elena Zamagni speaks to ecancer about her presentation at EMN 2024 on 'Complementing clinical trials: Investigating the value of real world evidence with insights from TE NDMM'.
She explains that the conversation focused on the how to balance clear, non-bias clinical trials with real life patients and trial eligibility.
Dr Zamagni also presented on the combination of daratumumab-VTD in real life and reports that elderly patients with renal failure/high-risk cytogenetics could still benefit from the combination.
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for August 25th - 31st, 2023
NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres
Choosing Wisely in radiology Tanzania
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
